loadpatents
Patent applications and USPTO patent grants for Goodwin; Raymond G..The latest application filed is for "use of trail polypeptides to treat cancer".
Patent | Date |
---|---|
Methods of use of the TACI/TACI-L interaction Grant 8,133,976 - Goodwin , et al. March 13, 2 | 2012-03-13 |
DNA encoding a soluble fragment of TRAIL polypeptide Grant 7,972,812 - Wiley , et al. July 5, 2 | 2011-07-05 |
Use of Trail Polypeptides to Treat Cancer App 20100323399 - Wiley; Steven R. ;   et al. | 2010-12-23 |
Methods Of Use Of The Taci/taci-l Interaction App 20100196404 - GOODWIN; RAYMOND G. ;   et al. | 2010-08-05 |
Use of TRAIL polypeptides to induce apoptosis Grant 7,736,637 - Wiley , et al. June 15, 2 | 2010-06-15 |
Purified TNFR preparations App 20090270592 - Smith; Craig A. ;   et al. | 2009-10-29 |
CD30 Ligand App 20090264349 - Goodwin; Raymond G. ;   et al. | 2009-10-22 |
Use of TRAIL Polypeptides to Treat Cancer App 20090118186 - Wiley; Steven R. ;   et al. | 2009-05-07 |
Methods of use of the TACI/TACI-L interaction App 20090081700 - Goodwin; Raymond G. ;   et al. | 2009-03-26 |
Glycoproteins which bind to TNF Grant 7,459,528 - Smith , et al. December 2, 2 | 2008-12-02 |
Receptor that causes cell death and recombinant production thereof Grant 7,416,877 - Degli-Esposti Rankin , et al. August 26, 2 | 2008-08-26 |
NK cell activation inducing ligand (NAIL) DNA and polypeptides, and use thereof App 20080081043 - Kubin; Marek Z. ;   et al. | 2008-04-03 |
Novel receptor that causes cell death App 20070298460 - Degli-Esposti Rankin; Mariapia A. ;   et al. | 2007-12-27 |
CD30 ligand Grant 7,232,660 - Goodwin , et al. June 19, 2 | 2007-06-19 |
4-1BB polypeptides and DNA encoding 4-1BB polypeptides Grant 7,211,259 - Goodwin , et al. May 1, 2 | 2007-05-01 |
Antibodies to human 4-1BB Grant 7,138,500 - Goodwin , et al. November 21, 2 | 2006-11-21 |
Cytokine designated 4-1BB ligand and human receptor that binds thereto App 20060127985 - Goodwin; Raymond G. ;   et al. | 2006-06-15 |
Antibodies which specifically bind to TNF-R Grant 7,057,022 - Smith , et al. June 6, 2 | 2006-06-06 |
Cytokine designated 4-1BB ligand and human receptor that binds thereto App 20060110802 - Goodwin; Raymond G. ;   et al. | 2006-05-25 |
Glycoproteins which bind to TNF App 20060067934 - Smith; Craig A. ;   et al. | 2006-03-30 |
Viral proteins capable of binding LAR App 20050176640 - Smith, Craig A. ;   et al. | 2005-08-11 |
Method of using a cytokine that induces apoptosis App 20050158823 - Wiley, Steven R. ;   et al. | 2005-07-21 |
Viral proteins capable of binding LAR Grant 6,852,486 - Smith , et al. February 8, 2 | 2005-02-08 |
CD 30 ligand App 20040241758 - Goodwin, Raymond G. ;   et al. | 2004-12-02 |
Novel receptor that causes cell death App 20040180826 - Degli-Esposti Rankin, Mariapia A. ;   et al. | 2004-09-16 |
Cytokine that induces apoptosis App 20040052788 - Wiley, Steven R. ;   et al. | 2004-03-18 |
CD30 ligand Grant 6,667,039 - Goodwin , et al. December 23, 2 | 2003-12-23 |
Methods of use of the TACI/TACI-L interaction App 20030165986 - Goodwin, Raymond G. ;   et al. | 2003-09-04 |
Antibodies which specifically bind to TNF-R App 20030165459 - Smith, Craig A. ;   et al. | 2003-09-04 |
Method for suppressing inflammatory responses by administering TNFR Grant 6,572,852 - Smith , et al. June 3, 2 | 2003-06-03 |
Viral proteins capable of binding LAR App 20030049609 - Smith, Craig A. ;   et al. | 2003-03-13 |
Antibodies directed against trail Grant 6,521,228 - Wiley , et al. February 18, 2 | 2003-02-18 |
Methods Of Use Of The Taci/taci-l Interaction App 20030022233 - GOODWIN, RAYMOND G. ;   et al. | 2003-01-30 |
Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto Grant 6,355,779 - Goodwin , et al. March 12, 2 | 2002-03-12 |
Tumor Necrosis factor-alpha and -beta receptors App 20020006391 - Smith, Graig A. ;   et al. | 2002-01-17 |
Cytokine that induces apoptosis Grant 6,284,236 - Wiley , et al. September 4, 2 | 2001-09-04 |
Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors Grant 6,156,301 - Namen , et al. December 5, 2 | 2000-12-05 |
CD30 ligand oligomers and polypeptides Grant 6,143,869 - Goodwin , et al. November 7, 2 | 2000-11-07 |
DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors Grant RE36,755 - Smith , et al. June 27, 2 | 2000-06-27 |
Purified p75 (type II) tumor necrosis factor receptor polypeptides Grant 5,945,397 - Smith , et al. August 31, 1 | 1999-08-31 |
Cytokine which is a ligand for OX40 Grant 5,783,665 - Baum , et al. July 21, 1 | 1998-07-21 |
DNA encoding a cytokine that induces apoptosis Grant 5,763,223 - Wiley , et al. June 9, 1 | 1998-06-09 |
DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors Grant 5,712,155 - Smith , et al. * January 27, 1 | 1998-01-27 |
Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors Grant 5,705,149 - Namen , et al. January 6, 1 | 1998-01-06 |
Cytokine designated 4-IBB ligand Grant 5,674,704 - Goodwin , et al. October 7, 1 | 1997-10-07 |
CD27 ligand Grant 5,573,924 - Beckmann , et al. November 12, 1 | 1996-11-12 |
CD30 ligand Grant 5,480,981 - Goodwin , et al. January 2, 1 | 1996-01-02 |
Isolated viral protein TNF antagonists Grant 5,464,938 - Smith , et al. November 7, 1 | 1995-11-07 |
Cytokine which is a ligand for OX40 Grant 5,457,035 - Baum , et al. Oc | 1995-10-10 |
DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors Grant 5,395,760 - Smith , et al. March 7, 1 | 1995-03-07 |
Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists Grant 5,359,039 - Smith , et al. October 25, 1 | 1994-10-25 |
Interleukin-7 Grant 5,328,988 - Namen , et al. July 12, 1 | 1994-07-12 |
Interleukin-7 receptors Grant 5,264,416 - Park , et al. November 23, 1 | 1993-11-23 |
DNA encoding interleukin-7 receptors and methods of use Grant 5,194,375 - Park , et al. March 16, 1 | 1993-03-16 |
Interleukin-7 Grant 4,965,195 - Namen , et al. October 23, 1 | 1990-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.